These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 34047434)

  • 21. Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study.
    Dai G; Ran Y; Wang J; Chen X; Peng J; Li X; Deng H; Xiao M; Zhu T
    Mediators Inflamm; 2020; 2020():1059079. PubMed ID: 33273887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COPD exacerbation phenotypes in a real-world five year hospitalisation cohort.
    Jones TPW; Brown J; Hurst JR; Vancheeswaran R; Brill S
    Respir Med; 2020 Jun; 167():105979. PubMed ID: 32421545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.
    Choi J; Oh JY; Lee YS; Hur GY; Lee SY; Shim JJ; Kang KH; Min KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():953-959. PubMed ID: 31190782
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood eosinophils: a biomarker of response to glucocorticoids and increased readmissions in severe hospitalized exacerbations of COPD].
    Xue J; Cui YN; Chen P; Cai S; Chen L; Dai ZS; Chen Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):426-431. PubMed ID: 31189228
    [No Abstract]   [Full Text] [Related]  

  • 25. A Revised Treatment Approach for Hospitalized Patients with Eosinophilic and Neutrophilic Exacerbations of Chronic Obstructive Pulmonary Disease.
    Aksoy E; Güngör S; Ağca MÇ; Özmen İ; Duman D; Koçak ND; Aktürk ÜA; Tunçay E; Saltürk C; Yalçınsoy M; Ocaklı B; Karakurt Z
    Turk Thorac J; 2018 Oct; 19(4):193-200. PubMed ID: 30322438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
    Pavord ID; Chanez P; Criner GJ; Kerstjens HAM; Korn S; Lugogo N; Martinot JB; Sagara H; Albers FC; Bradford ES; Harris SS; Mayer B; Rubin DB; Yancey SW; Sciurba FC
    N Engl J Med; 2017 Oct; 377(17):1613-1629. PubMed ID: 28893134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses.
    Csoma B; Bikov A; Tóth F; Losonczy G; Müller V; Lázár Z
    ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33585654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of IL-13 and ECP in the serum and sputum of eosinophilic AECOPD patients.
    Li T; Gao L; Ma HX; Wei YY; Liu YH; Qin KR; Wang WT; Wang HL; Pang M
    Exp Biol Med (Maywood); 2020 Aug; 245(14):1290-1298. PubMed ID: 32493123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations.
    Ko FWS; Chan KP; Ngai J; Ng SS; Yip WH; Ip A; Chan TO; Hui DSC
    Respirology; 2020 Mar; 25(3):259-266. PubMed ID: 31385389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
    Moll K; Sun SX; Ellis JJ; Howe A; Amin A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis.
    Jabarkhil A; Moberg M; Janner J; Petersen MN; Jensen CB; Henrik Äangquist L; Vestbo J; Jess T; Porsbjerg C
    Eur Clin Respir J; 2020; 7(1):1757274. PubMed ID: 32489532
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease.
    Wang Y; Chang C; Tian S; Wang J; Gai X; Zhou Q; Chen Y; Gao X; Sun Y; Liang Y
    Front Mol Biosci; 2023; 10():1204985. PubMed ID: 37503537
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood Eosinophil Levels and Prognosis of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Yu S; Zhang J; Fang Q; Tong Z
    Am J Med Sci; 2021 Jul; 362(1):56-62. PubMed ID: 33617785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy.
    Benson VS; Pascoe KC; Siddall J; Small M; Müllerová H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2711-2723. PubMed ID: 31819403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Influenza PCR Positivity in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Chen CYJ; Yew MS; Abisheganaden JA; Xu H
    Int J Chron Obstruct Pulmon Dis; 2022; 17():25-32. PubMed ID: 35023911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
    Wang J; Chai J; Sun L; Zhao J; Chang C
    BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
    Jiang M; Ma JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of Exhaled Nitric Oxide (FeNO) And Eosinophilia During the Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospital Admission.
    Río Ramírez MT; Juretschke Moragues MA; Fernández González R; Álvarez Rodríguez V; Aznar Andrés E; Zabaleta Camino JP; Romero Pareja R; Esteban de la Torre A
    COPD; 2018; 15(4):369-376. PubMed ID: 30064275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.